Stockwatch: Trench warfare
This article was originally published in Scrip
Executive Summary
As Europeans marked 70 years since the end of the war in Europe last weekend, conflict of a different sort was being waged between investors and investment bank analysts. Writers on behavioral finance typically think of conflict in the context of investors buying and selling the same stock. However, at times last week a much more malevolent force was working, one reminiscent of the way incompetent and distant general staff in the Great War ordered soldiers to their certain death from a fusillade of machine fire in the brutal European battlefields as they dressed for a regimental dinner many miles away.
You may also be interested in...
Stock Watch: Risk And The Pharmaceutical Discount Rate
In contrast to the SEC’s view that public companies’ regulatory filings give investors all the information needed to make an investment decision, the discount rate used to value a company may not reflect all its risks.
Stock Watch: Pharma Businesses That Leave Consumer Behind
Healthcare conglomerates that divorce consumer, animal health and even generics businesses from their pure-play branded pharmaceutical groups could leave a less diversified and riskier sector in uncertain times. But the advantages are apparent.
Stock Watch: Acadia And Amylyx Trial Failures Were No Shock
The overused phrase ‘pipeline in a product’ translates to ‘disappointment in a product’ when the number of indications in the pipeline contracts towards zero.